Gilead Sciences (GILD)

Company Ticker Sector | Industry Quality PAR
Gilead Sciences GILD Healthcare | Biotechnology 60 4.5%
Current Price (02/27) $72.66
CAPS Rating (Rate this stock on CAPS) Foolcaps 4
Expected Income Statement
Current Sales 22,449.0
Sales Growth Forecast 0.8%
Net Profit Margin 34.5%
Projected Shares Outstanding 1,250.38
EPS - Five year Forecast $6.44
Average P/E Ratio 12.0
Projected Average Price $77.23
Price Appreciation (Annualized) 1.2%
Annual Dividend Yield 3.3%
Projected Annual Return 4.5%
Quality
Financial Strength 89 22.2
EPS Stability 52 12.9
Industry Sales Growth Rate 16.5% 0.6
Industry Net Profit Margin 29.0% 14.9
Calculated Quality Rating 50.6
Fool CAPS

Total Players

3414 Outperforms
87 Underperforms
 

All-Stars (637)

624 Outperforms (98%)
13 Underperforms
 
Fundamental Data Updated: 01/03/2020

MIPAR 10.8%  
Sweet Spot 15.8% - 20.8%  

Top In Biotechnology

Ticker Quality PAR
JAZZ 95 19.2%
REGN 81 18.8%
BIIB 75 13.8%
AMGN 88 10.5%
CBPO 72 13.2%

Top In Healthcare

Ticker Quality PAR
ALGN 98 19.6%
JAZZ 95 19.2%
ABBV 91 19.2%
UNH 96 15.8%
REGN 81 18.8%